Sui Peng

577 citations
24 papers · 402 indexed · h-index 11
Topics
Hepatocellular Carcinoma Treatment and Prognosis (19 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers)Radiomics and Machine Learning in Medical Imaging (4 papers)
Partner nations
ChinaUnited StatesPoland

In The Last Decade

Sui Peng

21 papers receiving 399 citations

Peers

Sui Peng
Comparison fields: 5 of 55
  • Hepatology 215
  • Cancer Research 129
  • Molecular Biology 114
  • Oncology 91
  • Pulmonary and Respiratory Medicine 83
Replace Ernest Belmonte with:
Ernest Belmonte Spain
Tongguo Si China
Xiao-Dong Zhu China
Long-Zi Liu China
Zu-Shun Chen China
Yongliang Sun China
Ruoyu Shi China
Laurence Crouzet France
Sui Peng relative to Ernest Belmonte Spain Ernest Belmonte's profile →
Citations per field
00.5×2.7×
Ernest Belmonte · 1×
Citations per year

Countries citing papers authored by Sui Peng

Since Specialization
Citations

This map shows the geographic impact of Sui Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sui Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sui Peng more than expected).

Fields of papers citing papers by Sui Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sui Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sui Peng. The network helps show where Sui Peng may publish in the future.

Co-authorship network of co-authors of Sui Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Sui Peng. A scholar is included among the top collaborators of Sui Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sui Peng. Sui Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 14
5 46
6 8
7 26
8 2
9 4
10 17
11 3
12 29
13 5
14 17
15 90
16 54
17 13
18 47
19
Pretreatment prediction of Immunoscore in hepatocellular cancer: a radiomics-based clinical nomogram based on Gd- EOB-DTPA enhanced-MRI
1
20 5

About Sui Peng

Sui Peng is a scholar working on Hepatology, Cancer Research and Oncology, having authored 24 papers that have together received 402 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). The work is most often cited by research in Hepatology (215 citations), Cancer Research (129 citations) and Oncology (91 citations). Sui Peng has collaborated with scholars based in China, United States and Poland. Frequent co-authors include Zhenwei Peng, Ming Kuang, Junbin Liao, Shuling Chen, Yu Guo, Tianhong Su, Qian Zhou, Han Xiao, Shi‐Ting Feng and Zunfu Ke. Their work appears in journals such as Journal of Clinical Oncology, Hepatology and Radiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026